Meanwhile, the simplified score (≥3) provides a lighter yet efficient alternative, detecting more cancers (75 versus 70) and sparing more colonoscopies (64.1% versus 60.8%) compared to FIT ≥ 100 ng Hb g−1 (Figure 18). The gene discussed is GSTM1; the disease is cancer.